Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a cheap steroid save ICU patients from deadly pneumonia?

NCT ID NCT05354778

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 22 times

Summary

This study tests whether adding the steroid hydrocortisone to standard treatment can reduce deaths and complications in ICU patients with severe hospital-acquired pneumonia. About 180 adults in the ICU will receive either hydrocortisone or a placebo. The goal is to see if this inexpensive drug improves survival and recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR-ASSOCIATED PNEUMONIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital do Servidor Publico Estadual

    RECRUITING

    São Paulo, Sao Paulo SP, 04039-901, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.